Fusilev: Clinical Trials

2 trials of Fusilev, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 withdrawn. 2 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 12Withdrawn 2

Follow Fusilev: new trials by email Literature Review of Fusilev trials Research Report on Fusilev

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Phase 1 Study of Fusilev® to Prevent or Reduce Mucositis in Patients With Non-Small Cell Lung Cancer Receiving Folotyn®
Folotyn, Fusilev - Non-Small Cell Lung Cancer
Phase 1WithdrawnAcrotech Biopharma Inc.2013-04-012020-01-23
Phase 1 Study of Fusilev to Prevent or Reduce Mucositis in Patients With Non-Hodgkin's Lymphoma Receiving Folotyn
Fusilev, Folotyn - Non Hodgkin's Lymphoma
Phase 1WithdrawnAcrotech Biopharma Inc.2013-03-012020-01-23

Conditions studied

Carcinoma, Non-Small-Cell Lung (1)  ·  Lymphoma, Non-Hodgkin (1)

Sponsors

Acrotech Biopharma Inc. (2)

Top investigators

Ahmed Sawas, MD (1)